Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of atherogenic lipoproteins is a research paper published in Cell Genomics (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
University of California, Los Angeles
Grant: P30 DK063491
University of California, Los Angeles
Grant: T32 GM008666
National Heart, Lung, and Blood Institute
Grant: S10 OD026929
National Heart, Lung, and Blood Institute
Grant: R01HL142711
National Heart, Lung, and Blood Institute
Grant: R01HL127564
National Institute of General Medical Sciences
Grant: R01GM129523
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1R01DK123422
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1R01DK125490
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 1R03DK113328
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P30DK120515
NIDDK NIH HHS
Grant: R01 DK123422
NIGMS NIH HHS
Grant: R35 GM131881
NIDDK NIH HHS
Grant: R01 DK125490
NIDDK NIH HHS
Grant: R03 DK113328
Alnylam Pharmaceuticals
University of California, San Diego
NIH
FWCI
5.02
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals